These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 91856)
1. Pergolide and lisuride for Parkinson's disease. Lieberman AN; Leibowitz M; Neophytides A; Kupersmith M; Mehl S; Kleinberg D; Serby M; Goldstein M Lancet; 1979 Nov; 2(8152):1129-30. PubMed ID: 91856 [No Abstract] [Full Text] [Related]
2. Lisuride in Parkinson's disease. Schachter M; Blackstock J; Dick JP; George RJ; Marsden CD; Parkes JD Lancet; 1979 Nov; 2(8152):1129. PubMed ID: 91855 [No Abstract] [Full Text] [Related]
3. Lisuride and pergolide in Parkinson's disease. Lang AE; Sheehy MP; Quinn NP; Brincat S; Marsden CD; Parkes D Adv Neurol; 1983; 37():109-20. PubMed ID: 6858769 [No Abstract] [Full Text] [Related]
4. Pergolide and lisuride in advanced Parkinson's disease. Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Goldstein M Adv Neurol; 1984; 40():503-7. PubMed ID: 6695627 [TBL] [Abstract][Full Text] [Related]
5. [Oral lisuride in Parkinson's disease]. Obeso JA; Luquin MR; Martínez Lage JM Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822 [No Abstract] [Full Text] [Related]
6. Lisuride, a dopamine agonist in the treatment of early Parkinson's disease. Rinne UK Neurology; 1989 Mar; 39(3):336-9. PubMed ID: 2927639 [TBL] [Abstract][Full Text] [Related]
7. [Optimization of the treatment of Parkinson's disease using dopamine agonists]. Rinne UK Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430 [No Abstract] [Full Text] [Related]
11. [Use of dopamine agonists in the treatment of Parkinson's disease]. Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):54-8. PubMed ID: 12378886 [No Abstract] [Full Text] [Related]
12. Lisuride infusion pump in Parkinson's disease. A report of two cases. Gershanik OS; Scipioni O; García S J Neural Transm Suppl; 1988; 27():85-90. PubMed ID: 2969955 [TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease: new drugs help but no cure on the horizon. González ER JAMA; 1981 Jul; 246(1):11-2. PubMed ID: 7241717 [No Abstract] [Full Text] [Related]
14. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease. Agnoli A; Stocchi F; Carta A; Antonini A; Bragoni M; Ruggieri SA Mt Sinai J Med; 1988 Jan; 55(1):62-6. PubMed ID: 3258057 [No Abstract] [Full Text] [Related]
15. Lisuride combined with levodopa in advanced Parkinson disease. Lieberman AN; Goldstein M; Leibowitz M; Neophytides A; Gopinathan G; Walker R; Pact V Neurology; 1981 Nov; 31(11):1466-9. PubMed ID: 7031504 [TBL] [Abstract][Full Text] [Related]
18. [Effect of lisuride in the "on-off" phenomena due to L-dopa]. Piccinin GL; Piccirilli M; Rizzo PA; Agostini L Clin Ter; 1983 Mar; 104(6):469-71. PubMed ID: 6851447 [No Abstract] [Full Text] [Related]
19. The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease. Lieberman AN; Leibowitz M; Gopinathan G; Walker R; Hiesiger E; Nelson J; Goldstein M Am J Med Sci; 1985 Sep; 290(3):102-6. PubMed ID: 4050844 [TBL] [Abstract][Full Text] [Related]
20. Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration. Stocchi F; Ruggieri S; Antonini A; Baronti F; Brughitta G; Bellantuono P; Bravi D; Agnoli A J Neural Transm Suppl; 1988; 27():27-33. PubMed ID: 3165437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]